Member access

4-Traders Homepage  >  Shares  >  Oslo Bors  >  Photocure ASA    PHO   NO0010000045

PHOTOCURE ASA (PHO)

4
SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops and sells pharmaceuticals and medical devices

Photocure ASA develops and markets pharmaceuticals and medical devices based on proprietary photodynamic technology.

It operates through the Cancer and Dermatology segments.

The Cancer segment consists of the sale from Hexvix to pharmaceutical wholesalers in Nordic markets and Cysview in the United States.

The Dermatology segment involves sale of MAL substance and the deferred recognition of Metvix revenue from Galderma.

The company was founded on August 27, 1993 and is headquartered in Oslo, Norway.

Number of employees : 50 persons.
Sales per Businesses
2012
NOK (in Million)%
Cancer115.5486.3%
Dermatology18.2813.7%
Managers
NameAgeSinceTitle
Kjetil Hestdal PhD, MD541997President, Chief Executive Officer & Press Contact
Åse Aulie Michelet621996Chairman
Kathleen Deardorff PharmD552011Chief Operating Officer & IR Contact
Erik Dahl-2012Chief Financial Officer & IR Officer
Inger Ferner Heglund592006Vice President-Research & Development
Jon Hindar582006Independent Director
Eva Steiness MD, DSc732008Independent Director
Mats Gunnar Pettersson, CPA692008Independent Director
Xavier Denis Yon732011Independent Director
Grete Hogstad582005Vice President-Strategic Marketing
Shareholders
NameShares%
Radiumhospitalets Forskningsstiftelse 3,029,00014.2%
Fondsfinans Kapitalforvaltning ASA 1,210,0005.66%
KLP Kapitalforvaltning AS 1,201,2585.62%
Tharald Brovig 931,4164.35%
Danske Capital AS 922,2284.31%
Skagen AS 735,8633.44%
MP Pensjon 700,0003.27%
DNB Asset Management AS 691,0883.23%
Eika Kapitalforvaltning AS 528,2982.47%
Odin Forvaltning AS 521,0272.44%
Holdings
NameShares%Valuation
PCI Biotech Holding ASA (PCIB) 1,483,33919.2%6,768,491 USD
Photocure ASA (PHO) 72,9760.34%261,635 USD
Sector
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Pharmaceuticals - NEC
Advertisement
Surperformance© rating
Overall rating
Trading Rating -
Investor Rating
Growth (Revenue) -
Valuation -
Finances
Profitability
Earnings quality
Business Predictability
PER -
Potential -
Yield
Consensus -
7 days EPS revision -
4 months EPS revision -
1 year EPS revision
4 months Revenue revision -
1 year Revenue revision
More Ratings
Sector Pharmaceuticals
Growth (Revenue) Profitability
JOHNSON & JOHNSON
ROCHE HOLDING LTD..
NOVARTIS AG
PFIZER INC.
MERCK & CO., INC.
SANOFI
GLAXOSMITHKLINE P..
BAYER AG
NOVO NORDISK A/S
BRISTOL-MYERS SQU..
ELI LILLY AND CO
ABBOTT LABORATORI..
ACTAVIS PLC
TEVA PHARMACEUTIC..
ALLERGAN, INC.
SHIRE PLC
VALEANT PHARMACEU..
TAKEDA PHARMACEUT..
ASTELLAS PHARMA I..
REGENERON PHARMAC..
Sector Pharmaceuticals
Company contact information
Photocure ASA
Hoffsveien 4
Oslo 0275

Phone : +47.22.06.22.10
Fax : +47.22.06.22.18
Web : www.photocure.com
© 2014 Factset   
Dynamic quotes  
ON
| OFF